AMITIZA has been on market for seven years and 7 million prescriptions for the drug in the US since the market launch in April 2006.
More than half of these patients did not respond to treatment with this drug
Linzess market opportunity is HUGE
Hahahaha! And more than 1/2 won't respond to Linzess too. Another 1/4 won't afford it and another 1/4 won't tolerate the adverse reactions. Mark this post genius stocktechdoc, 1st quarter royalties for IRWD will be less than $2 million. People will then realize that this doesn't quite deserve the $2 billion market cap.
And you know how I know sales will suck? Not a word has been mentioned about it! All anyone has said was 20,000+ pills per week growth, which only amounts to 650 scripts a week growth! Also, Forest fudged the numbers good by saying $19.2 million sales in first 15 days after launch. That was to stock the drug at wholesales where it will sit collecting dust! The trend has come to an end. Slow bleed going forward till earning then collapse will occur.
Mark this post my man! I'll bump it up for you in about 6 weeks.